I graduated from Swansea University in 2016 with a first-class degree in Medical Genetics and received the Jim Parry award. During my studies, I completed an industrial year at GSK, honing skills in various genetic toxicology assays. I pursued a PhD at Swansea University, focusing on genotoxic endpoint analysis and assay development with high content imaging. Here, as PGR representative, I organised the medical school PGR conference, fostering a passion for scientific communication and engagement. My work at Helix3 in the USA involved the GLP comet assay to support regulatory submissions and feasibility assessment of investigative/mechanistic studies. Currently employed at GSK, I have expanded my knowledge of the drug development pipeline, DNA damage assays, benchmark dose analysis, and data handling. Alongside this, I support junior scientists and continue work on mode and mechanism of action with promising use of deep learning for mining of high content image data. A UKEMS member since 2014, I joined the NUKEMS committee in May 2022 and became chair in July 2023.

I recently graduated from Brunel University London with a Bachelor’s in Biomedical Sciences, Genetics, and have started my PhD at Swansea University. Throughout my academic career, I had the incredible opportunity to intern in various laboratories and fields, including Molecular Medicine and Cellular Technology and the Republican Cancer Center in Uzbekistan, the Myogen Genetic Diseases and Diagnostic Centre in Turkey, and notably, a placement year at GSK in the Department of Genetic Toxicology and Photosafety. Here in Swansea, my PhD project involves optimizing an in vitro safety assessment, aligned with the 3R principle, focusing on cancer energy metabolism and using metabolic alterations as endpoints to detect genotoxicity.
I have been a member of the UKEMS since 2021, during which I presented my research on the genotoxic potential of NDMA in mice, using Flow Cytometry Pig-A and Micronucleus Assays. This work earned me the Best Overall Presentation Award during the UKEMS 2022 Conference in Harrogate.

I graduated with a BSc (Hons) in Biomedical Science from Northumbria University in 2019, during which I trained as a biomedical scientist at the NHS Northern Genetics Service. After graduating, I joined the genetic toxicology team at Labcorp in Harrogate, followed by roles as a research biomedical scientist in cellular pathology and a research technician at the Wolfson Childhood Cancer Research Centre. I later returned to Labcorp, where I now work as a technical specialist in genetic toxicology. In this role, I perform regulatory genotoxicity assays including in vivo micronucleus, comet, and transgenic rodent assays. I lead validation projects focused on innovative tools and emerging testing methods and was honoured with the ‘New Investigator Technical Award’ at the 2024 Industrial Genotoxicology Group conference, where I presented some of my work. I’m passionate about supporting early career scientists and I’m excited for the opportunity to do this as a NUKEMS committee member.

I graduated from Sheffield Hallam University in 2019 with a BSc in Human Biology and joined Gentronix Ltd. in 2020 as a Study Technician, progressing to my current role of Senior Scientist. My experience has focussed on the Bacterial Reverse Mutation assay, working under current regulatory guidelines and GLP standards. I am involved in routine testing along with ensuring quality control of data and study reports and a current member of the Health and Safety committee. I recently presented at IGG for the validation of the Enhanced Ames assay and was awarded ‘The Technical Investigator Award’ for early career scientists. I am looking forward to sharing my industrial experience to support other early career scientists.

I am a final year PhD student in the In Vitro Toxicology Group (IVTG) at Swansea University. My project is in collaboration with AstraZeneca and investigates the use of automated high-content imaging for in vitro genotoxicity testing. I obtained my Bachelor of Science and Masters in Toxicology from the University of Galway, Ireland. Before starting my PhD, I was a Toxicology Trainee in the Scientific Committee and Emerging Risks unit at the European Food Safety Authority (EFSA) Italy and worked as a Junior Toxicologist at Delphic HSE, UK.

I began my scientific career as a degree apprentice at GSK in 2017. Whilst working in the Genetic Toxicology team at GSK, I completed a BSc in Applied Bioscience from the University of Kent, where my final year project focussed on investigation of both epigenetic and aneugenic mechanisms using flow cytometry-based assays. Since completing my undergraduate degree, I have continued my career at GSK whilst pursuing an MSc with Swansea University, investigating the HPRT assay for nitrosamine risk assessment. In my role at GSK, I am responsible for study directing non-GLP pivotal gene tox screening assays as well as performing genotoxic risk assessments, looking at potential genotoxicity at a structural level. I have been a member of UKEMS since I began my career in 2017 and I am now really looking forward to supporting early career scientists in the NUKEMS community.

I am a PhD student at Swansea University with a project based in genetic toxicology and the development of quantitative Adverse Outcome Pathways using 3D liver models. I graduated from Swansea University with a BSc in biochemistry and genetics in 2020, after which I undertook an MRes investigating the gut microbiome and colorectal cancer. Following this, I worked as an innovation and research assistant in the Healthcare and Technology Centre in Swansea University supporting the delivery of healthcare related projects that collaborated academia and industry, and then moved on to the world of toxicology whereby I worked as a nanomedical research assistant. I am thoroughly enjoying my PhD project and keen to pursue a career in genetic toxicology, and I am pleased to have the opportunity to support other early career researchers.